| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10911037 | Lung Cancer | 2013 | 6 Pages |
Abstract
Favorable response of BM to gefitinib even without irradiation was demonstrated. Exon 19 deletion was both a predictive and prognostic marker of patients with BM treated by gefitinib.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
T. Iuchi, M. Shingyoji, T. Sakaida, K. Hatano, O. Nagano, M. Itakura, H. Kageyama, S. Yokoi, Y. Hasegawa, K. Kawasaki, T. Iizasa,